David Shapiro
CIK 1559570 · Chief Medical Officer · last filed 2026-06-11
David Shapiro is a Chief Medical Officer who has filed 82 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for DSGN, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$32.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
82
-$32.90M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | — | $10.97 | — | $0 | 2 | 2026-06-11 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | — | $28.69 | — | $0 | 4 | 2025-06-20 |
| VivoSim Labs, INC. (ONVO) Delisted | Director | — | $2.04 | — | $0 | 2 | 2019-09-09 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Chief Medical Officer | 41,499 | $19.00 | $788.5K | -$32.90M | 74 | 2019-05-03 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2026-04-01 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-09 | VivoSim Labs, INC. (ONVO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$108.8K | EDGAR |
| 2019-04-16 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$126.2K | EDGAR |
| 2019-04-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −1,044 | -$118.4K | EDGAR |